<DOC>
	<DOCNO>NCT01104350</DOCNO>
	<brief_summary>The purpose study test safety different amount ( dos ) external radiation therapy ( high-energy x-ray shrink destroy cancer ) combine chemotherapy .</brief_summary>
	<brief_title>Image-Guided Radiation Therapy Bladder-Cancer Patients Undergoing Radiotherapy Concurrent Gemcitabine Chemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<criteria>MSKCCreviewed pathologically proven diagnosis primary bladder urothelial carcinoma without evidence regional ( nodal ) distant spread ( cT1T4a , Nx N0 ) . Karnofsky Performance Scale ( KPS ) ≥ 70 % Age ≥18 year old Adequately function bladder , define continent without need indwell catheter Absolute neutrophil count ( ANC ) ≥ 1500/mL ; platelet ≥ 100,000/mm3 serum bilirubin &lt; 1.5 x upper limit normal ( ULN ) ; aspartate aminotransferase ( AST ) and/alanine aminotransferase ( ALT ) ≤ 1.5 × ULN Adequate renal function : calculated creatinine clearance &gt; 30 mL/min/1.73 m2 use follow formula modify Cockcroft Gault Formula estimate Creatinine Clearance Patients must consider able tolerate systemic chemotherapy pelvic radiation therapy . Patients must ability understand willingness sign write informed consent document Evidence distant disease histologicallyproven nodal metastasis . Patients radiologic evidence lymphadenopathy must biopsy proof N0 status . Previous pelvic radiation therapy Prior systemic chemotherapy noncisplatin base neoadjuvant urothelial carcinoma ( prior intravesical chemotherapy immunotherapy permissible ) Prior cisplatin base neoadjuvant systemic chemotherapy &gt; 4 cycle Active inflammatory bowel disease ( i.e. , Crohn 's disease ulcerative colitis ) Women pregnant lactating</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Bladder</keyword>
	<keyword>Radiotherapy</keyword>
	<keyword>Gemcitabine</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>10-031</keyword>
</DOC>